Oncology Research Institute (ORI)

Cell biology, molecular biology, and developmental biology researchers at Greenville Hospital System Oncology Research Institute are working to discover innovative approaches to cancer treatment. This is basic research – where a promising treatment begins with the question, “What if ... ?”

Current projects include a way to use lytic peptides to target prostate cancer cells and the development of a human prolactin antagonist to inhibit the growth of breast cancer cells.

Please contact Clinical Research Unit for current open trials at 864-679-3966.